Do hidden tissue targets escape immune attack by looking too much like healthy cells?
The hypothesis says tissue targets escape working immune defenses because their recognition signals resemble healthy cells. In matched cells from the same person, an independent distinguishing signal should restore selective killing better than an equally strong redundant signal.
Omega Point 1.2
Stage of verification
- Hypothesis published2026-09-21
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Immune response
Immune target discrimination
The process by which immune surveillance distinguishes infected or abnormal cells from healthy cells
Where this hypothesis actsTissue surveillance when abnormal target cells elicit recognition patterns resembling healthy cells
Hypotheses on this target 1
Inhibition
Activation
Function preservation
Clearance restoration
Immunosuppression
Feedback restoration
Rhythm restoration
What is proposed
Increase independent signals that distinguish abnormal target cells from healthy cells
With whatNot stated in the record
HowAdd independently discriminating signals through controlled target-cell activating and inhibitory ligands while preserving healthy-self discrimination
Possible result
Possible restoration of selective killing and greater recognition robustness to ligand variation
From the recordIncreasing independent target-discrimination signals, while preserving healthy-self discrimination, would stabilize SPV_11.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Restoring immune performance on a set of tests may still leave abnormal cells hidden in the body. The unexpected move is to propose that several working recognition systems can all supply nearly the same information, leaving too little distinction between dangerous and healthy cells. This is a pipeline-generated hypothesis, not a measured result.
- Abnormal target cells are proposed to alter displayed protein fragments, stress signals, and signals that restrain immune attack together.
- Those coordinated changes are proposed to make different recognition routes repeat nearly the same information about whether a cell is dangerous.
- Ordinary target-cell variation is then proposed to shift a barely distinguishable abnormal cell into a state that looks like healthy tissue.
- Working immune cells would consequently fail to attack those targets, while still passing tests against other, distinguishable targets.
- Adding a genuinely independent distinguishing signal is predicted to restore selective killing more reliably than strengthening information already present.
Several witnesses may seem to provide several independent clues, but if all repeat the same observation, losing that one clue leaves little to distinguish two suspects.
Where the picture breaks: Immune cells do not compare witness statements. Their signals interact biologically, and the proposal must establish that the measured differences actually predict recognition and killing.
- Master questionstep 01 of 04
Lasting immune restoration in older people would require both immediate defenses and defenses learned through past exposure to work within healthy young-adult ranges, while retaining protection from previous encounters, avoiding attacks on healthy tissue, and controlling infections that remain in the body.
Rests on: The goal defines success as a combination of restored function, durability, and preserved protection, rather than improvement on a single measurement.
Stated in the chain - Goal pillarstep 02 of 04
Recovery must withstand repeated demands, and the immune system's monitoring of tissues must resist interruptions.
Rests on: The master question requires restoration to last while protective functions remain intact.
Stated in the chain - Gap questionstep 03 of 04
Normal results across several kinds of immune-function tests might repeatedly coexist with failed tissue monitoring that predicts later harm. Such a finding would show that recovery in the tested functions is insufficient to establish recovery of the whole system.
Rests on: The preceding pillar requires resistance to interrupted tissue monitoring. This question asks whether apparently complete recovery on tests can miss that failure; it does not report that this coexistence has been observed.
Stated in the chain - Hypothesisstep 04 of 04
Hidden abnormal cells are proposed to escape by presenting combinations of signals that look too much like healthy cells, even when immune recognition and killing machinery still work. Several recognition routes may repeat the same distinguishing information, allowing ordinary variation in target cells to erase what little difference remains.
Rests on: The gap question separates success against test targets from successful tissue monitoring. The endpoint supplies a proposed explanation for that separation and explicitly borrows from mathematics about distinguishing messages despite errors; its biological application remains to be tested.
Stated in the chain
What is carried, and what is not. Individual links have partial support: S3, an Oncoimmunology paper from 2018, reported that platelets, blood components involved in clotting, caused tumor cells to shed recognition signals and reduced killing through the affected immune-recognition route; it did not establish coordinated changes across routes, resemblance to healthy tissue, or failure missed by functional tests. No supplied source establishes the proposed sequence end to end, and the borrowed mathematics does not establish that immune cells behave according to its assumptions.S3
How a result here could mislead · 3
- Better killing after an added signal could be credited to new distinguishing information when the change actually increases immune-cell encounters, total stimulation, or the target's susceptibility to death. What closes it: The proposed fixed immune-cell population, encounter frequency, and target death susceptibility must be verified as fixed. The comparison requires an equally strong signal that repeats existing information, with matched healthy cells showing whether selective attack is preserved.
- A mathematical separation between healthy and abnormal response patterns could appear predictive because response thresholds were chosen after seeing the results, or because the imposed disturbances do not fit the model's error limit. What closes it: The channels, response thresholds, distance measure, and maximum number of changed channel responses must be fixed before validation. The model must predict perturbations, deliberately imposed signal changes, withheld from model development; immune cells cannot simply be assumed to make the mathematically optimal classification.
- Target survival alone could be read as failed recognition even when immune cells recognize the target and deliver killing molecules, but the target fails to complete the death process—the rival explanation. What closes it: Recognition responses and delivery of granzyme, an immune-cell enzyme that helps trigger target-cell death, must be measured alongside survival. The hypothesis predicts little delivery before recognition is restored and normal death afterward; repeated delivery despite survival instead supports a failure inside the target.
What would make this wrong. Escaping targets that remain independently distinguishable from matched healthy cells, repeatedly receive granzyme, and nevertheless survive would reject the proposed recognition failure as the explanation in the tested system. That observation would favor the rival location of failure inside the target's death process, without by itself establishing the rival's detailed mechanism.
What it would change. If this held, recovery on immune-function tests would not by itself establish the durable restoration sought in the master question. Assessment would also need to establish that abnormal tissue remains distinguishable from healthy tissue under changes in target signals, and that increasing this distinction preserves healthy cells. Even successful tests with engineered cells from the same person would not establish lasting restoration in older adults, preservation of learned protection, or control of persistent infections; the supplied material also does not define the endpoint's named stabilization measure.
Sources read · 10
EBV-associated diseases: Current therapeutics and emerging technologies. · Frontiers in immunology · 2022
“Latent EBV genes are reported to promote tumorigenesis, inhibit apoptosis, and suppress recognition of infected cells by host immune cells ( ).”
Does not settle: The source does not establish that infected cells escape by resembling healthy self through coordinated peptide–MHC, stress-ligand, and inhibitory-self-ligand changes; it does not assess receptor-pathway function, redundancy of recognition signals, ordinary target-cell variation, functional-panel limitations, or ways to increase independent discrimination signals.
NK Cells in the Tumor Microenvironment. · Advances in experimental medicine and biology · 2020
“NK cells express an array of germline-encoded receptors which allow them to eliminate transformed cells and spare normal, healthy cells.”
Does not settle: This abstract does not establish that occult tissue targets escape by becoming insufficiently distinguishable from healthy self, nor does it test coordinated changes in peptide–MHC, stress ligands, inhibitory self ligands, recognition-signal redundancy, or functional-panel limitations.
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells. · Oncoimmunology · 2018
“Platelet-mediated NKG2DL-shedding in turn resulted in impaired “induced self” recognition by NK cells as revealed by diminished NKG2D-dependent lysis of tumor cells.”
Does not settle: This source establishes impaired NK-cell recognition through reduced NKG2D ligands on tumor cells after platelet coating, but does not establish the proposed combined recognition code involving cognate peptide–MHC, stress ligands, and inhibitory self ligands, nor target indistinguishability from healthy tissue or functional-panel limitations.
NK cells and cancer immunosurveillance. · Oncogene · 2008
“Natural killer (NK) cells are lymphocytes of the innate immune system that monitor cell surfaces of autologous cells for an aberrant expression of MHC class I molecules and cell stress markers.”
Does not settle: The abstract indicates NK cells distinguish malignant from healthy cells through MHC class I and stress-marker signals and that tumours can escape NKG2D-mediated recognition, but it does not establish the proposed coordinated multi-ligand recognition code, signal redundancy, ordinary target-cell variation, functional-panel limitations, or SPV_11 stabilization.
Mitochondrial mass of circulating NK cells as a novel biomarker in severe SARS-CoV-2 infection. · International immunopharmacology · 2023
“NK-MM was not only associated with disease severity, its abnormal increases or decreases also predicted mortality risk.”
Does not settle: It does not examine occult tissue targets, healthy-self-like recognition, peptide-MHC or stress/inhibitory ligands, receptor-pathway function, target-cell killing, or whether functional panels miss a recognition failure.
Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response. · Critical care (London, England) · 2018
“Current data suggest that T cells play a key role in the initiation and propagation of the immune reaction in experimental AKI”
Does not settle: It does not establish that tissue targets escape immune attack through reduced distinction from healthy self, altered peptide–MHC/stress/inhibitory ligands, redundancy among recognition signals, or limitations of functional immune panels.
Clinical utility of tetramer-based immune monitoring in allogeneic stem cell transplantation. · BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2003
“Tetramer staining can be combined with functional assays of antigen-specific T cells measuring their production of intracellular cytokines after short-term stimulation with antigen.”
Does not settle: This abstract does not examine hidden tissue targets, resemblance to healthy self, coordinated peptide–MHC/stress/inhibitory-ligand alteration, recognition-signal redundancy, or whether functional panels miss such target-recognition failures.
Diversity index of mucosal resident T lymphocyte repertoire predicts clinical prognosis in gastric cancer. · Oncoimmunology · 2015
“Most importantly, the diversity of mucosal T lymphocytes could independently predict prognosis, which strongly underscores critical roles of resident mucosal T-cells in executing post-surgery immunosurveillance against tumor relapse.”
Does not settle: This source does not establish that occult targets evade attack by resembling healthy self, nor assess peptide–MHC, stress ligands, inhibitory self ligands, recognition-signal redundancy, target-cell variation, or functional assay limitations.
The Immune Escape Strategy of Rabies Virus and Its Pathogenicity Mechanisms. · Viruses · 2024
“Virulent strains inhibit IFN release more than avirulent ones [ ].”
Does not settle: This source text does not establish whether occult tissue targets evade immune attack by becoming insufficiently distinguishable from healthy self through coordinated peptide–MHC, stress-ligand, and inhibitory-self-ligand changes.
Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma. · Acta dermatovenerologica Croatica : ADC · 2018
“PD-L1 is highly expressed in about half of all melanomas and thus the role of PD1 in melanoma immune evasion is now well established (13).”
Does not settle: The abstract does not assess occult tissue targets, resemblance to healthy cells, coordinated peptide–MHC/stress/inhibitory-ligand changes, redundancy of recognition signals, or functional testing panels.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Can immune tests repeatedly show full recovery while tissue protection fails and predicts later illness?
Original wording · exactly as the pipeline generated it
Can complete recovery on multidomain functional panels repeatedly coexist with tissue surveillance failure that predicts subsequent clinical harm, falsifying sampled-domain recovery as a sufficient system state?
What this question is asking
The question concerns whether apparently restored immune function can coexist with hidden failures to protect the body's tissues. In people with age-related immune dysfunction, it asks whether repeated normal results across tests of several immune functions can occur alongside independently observed failures in tissue protection that predict later, clinically confirmed harm. The comparison is between apparently recovered people with and without those tissue failures and their later health outcomes. The question assumes that existing tests measure selected functions and that tissue measurements or digital methods might reveal failures those tests miss, although their coverage is not established. A repeated mismatch would challenge the claim that recovery on the measured functions is sufficient to establish recovery of the immune system as a whole.
- Age-related immune dysfunction
- Changes associated with aging that impair immune protection or regulation. Differences between older and younger people do not automatically establish impaired health outcomes, as S9 emphasizes.
- Multidomain functional panel
- A collection of tests measuring how several aspects of the immune system work. Multiple domains mean multiple selected functions, not necessarily coverage of the entire system; the supplied material does not specify the tests.
- Complete recovery and normalized panel results
- A judgment that all included test results have returned to specified acceptable ranges. The supplied material does not provide those ranges or establish that meeting them demonstrates recovery everywhere in the body.
- Tissue surveillance
- Immune monitoring and protection within particular parts of the body. A surveillance failure means that this protection is inadequate; an unusual tissue measurement alone does not establish such a failure.
- Digital methods
- Computer-based measurements or analyses. The pipeline mentions them without specifying what they measure or how reliably they detect clinically consequential failures.
- Recovery certification and sufficient system state
- Recovery certification is a judgment that recovery criteria have been met. Calling the measured state sufficient means that meeting those criteria is enough to establish the broader recovery claim.
- Clinical harm and clinical outcome
- Clinical harm is an adverse health event; a clinical outcome is a measured health result, whether adverse or otherwise. Adjudicated harm means an event formally assessed against defined criteria, which are not supplied here.
- Prediction and association
- Prediction connects a measurement to an outcome that occurs later; association means that findings occur together more or less often. Neither alone establishes that the measured abnormality causes the outcome.
- Secondary infection
- An infection arising after the initial illness or injury. S4 reports its association with persistent immune alterations after severe injury.
- Inflammation
- An immune response to injury or threat that can help protect the body but can also contribute to damage. A body-wide inflammation measurement need not describe all the protective functions of individual immune cells.
- Human immunodeficiency virus
- A virus that infects cells of the immune system. S8 uses this infection to describe a mismatch between tissue sites of persistence and blood-based measurements associated with control.
- Lymphoid tissue
- Parts of the body where immune cells gather and responses are organized. S8 identifies this tissue, along with the gut, as a site where the virus persists.
- Protective immune memory
- Retained capacity to respond to a previously encountered threat. Preserving this protection is part of the pipeline's broader recovery requirement.
- Self-tolerance
- Immune restraint that prevents damaging attacks on the body's own components. Restored protective activity would need to preserve this restraint under the broader question.
- Latent infections
- Infections that remain in the body in a largely inactive state and can become active again. Continued control of them is another part of the broader recovery requirement.
Functional panels sample selected functions, while tissue and digital methods expose potential blind spots without validated coverage.
A functional panel is a collection of tests of how parts of the immune system work; tissue measurements examine particular parts of the body, and digital methods are computer-based measurements or analyses whose form is not specified here. The assumption is that apparently normal test results can leave relevant tissue problems unmeasured and that other methods can reveal those problems. If established, this would provide a reason to question whether normal panels alone demonstrate recovery.
S5 describes limitations of the accessible measurements discussed in that source, and S8 identifies a mismatch between where an infection persists and where many measurements associated with its control are taken. These support the narrower concern that some measurements may miss relevant aspects of immune protection. S2 also states that its blood-based method is not ready for diagnostic use. None establishes the capabilities or coverage of the specific panels, tissue methods, or digital methods named by the pipeline, or demonstrates hidden tissue failure after panel-defined recovery.S2S5S8
The same question asked without the part nothing read establishes:
- In people with age-related immune dysfunction, can repeated normal results across several immune-function tests coexist with independently measured tissue-protection failures that predict later clinically confirmed harm?
- Among people whose immune-function tests have returned to normal, do tissue measurements distinguish those who later develop illness from those who do not?
- Normal tests coexist with tissue failure and later harm If independently established tissue failures repeatedly predicted later harm despite recovered test results, the measured functions would not capture all clinically consequential failures. Under those conditions, normal panel results would be insufficient to establish whole-system recovery.
- Tissue abnormalities coexist with normal tests but do not predict harm The measurements would disagree, but the proposed link from tissue abnormality to later illness would remain unestablished. That disagreement alone would not demonstrate that the recovery judgment conceals clinically consequential failure.
- No hidden tissue failure is observed after test recovery The observations would provide no counterexample to the recovery judgment within the people, tissues, and follow-up examined. They would not establish that the tests cover every relevant tissue or every later cause of harm.
A test panel measures the functions included in it, while the proposed recovery judgment extends to protection throughout the body. For that judgment to hold, normal measured functions would have to adequately represent the tissue protection needed to prevent illness. If tissue protection remained impaired and predicted later harm despite normal tests, a recovery judgment based on those tests could overlook a consequential failure. Conversely, an unusual tissue measurement without an established connection to later harm would not by itself show that clinically meaningful recovery had failed.
RL-3 functional panels sample selected functions; RL-1 tissue and digital methods expose potential blind spots without validated coverage.
Occult failures trigger investigation within justified detection windows; apparently normal panels cannot conceal clinically consequential surveillance deficits.
Attempt to falsify recovery certification using independently observed tissue dysfunction that precedes adjudicated harm despite normalized panel results.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
CROSS-DOMAIN TRANSFER: Occult tissue targets escape because their combined recognition signals become insufficiently distinguishable from healthy self, even though every participating receptor pathway and downstream killing mechanism remains functional. Coordinated alteration of cognate peptide–MHC, stress ligands and inhibitory self ligands creates a recognition code with little redundancy: apparently separate surveillance channels convey nearly the same discrimination information. Ordinary target-cell variation can then erase the few remaining distinguishing signals. Functional panels can correctly certify performance against their specified targets while leaving this real biological recognition failure unresolved. Increasing independent target-discrimination signals, while preserving healthy-self discrimination, would stabilize SPV_11.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Information theory and error-correcting codes: for binary codewords x and y, d_H(x,y) = sum from j=1 to n of 1[x_j != y_j]. Here n is the number of prespecified receptor-resolved surveillance channels; x_j and y_j are thresholded responses of channel j to two target conditions, with thresholds frozen before validation; 1[condition] equals one when that condition holds. Define d_cross as the minimum Hamming distance between any observed healthy-target response word and any infected or abnormal-target response word. Under a bounded model allowing at most t channel-response flips, d_cross >= 2t + 1 permits unambiguous separation of the two classes; t is the experimentally imposed maximum number of ligand-induced response flips per target encounter. This is the cross-class version of the disjoint Hamming-ball criterion, not a claim that every within-class target must be distinguishable. [MIT coding-theory lecture](https://courses.csail.mit.edu/6.440/spring08/notes/ST08-Lecture01.pdf). Biological implementation and the bounded-error assumption are hypotheses to test.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
With immune-cell composition, encounter frequency and target death susceptibility held fixed, failed tissue targets will produce recognition-response patterns close to those of matched healthy cells. In engineered autologous target panels, adding an independently discriminating signal will restore selective killing more effectively than adding an equally strong signal redundant with an existing one. Prespecified response-pattern distance should predict robustness to controlled ligand perturbations better than summed receptor activation. Escaping targets should receive little granzyme before recognition rescue and die normally afterward, unlike IH_Q_L3_M_G4_5_01. Normal independent recognition with repeated granzyme delivery despite survival would reject this explanation in favor of target-side execution failure.
Would tell it apart from at least one rival. The prediction specifies observable comparisons, responses to recognition rescue, and an explicit rejection condition. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
A fixed autologous effector population can be tested against target cells with independently controlled activating and inhibitory ligands. Matched healthy cells provide the essential self-tolerance comparator. The coding model must first predict held-out perturbations; immune cells cannot simply be assumed to implement an optimal mathematical decoder.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
With immune-cell composition, encounter frequency and target death susceptibility held fixed, failed tissue targets will produce recognition-response patterns close to those of matched healthy cells. In engineered autologous target panels, adding an independently discriminating signal will restore selective killing more effectively than adding an equally strong signal redundant with an existing one. Prespecified response-pattern distance should predict robustness to controlled ligand perturbations better than summed receptor activation. Escaping targets should receive little granzyme before recognition rescue and die normally afterward, unlike Persistent cell-death activity may protect abnormal cells from immune attack. Normal independent recognition with repeated granzyme delivery despite survival would reject this explanation in favor of target-side execution failure.
- What would separate them
Persistent cell-death activity may protect abnormal cells from immune attack predicts: In tissue cultures from panel-recovered participants, surviving abnormal cells will exhibit repeated granzyme delivery and sustained sublethal caspase activity. After this condition is established, target-restricted suppression of apoptotic caspases will increase irreversible target death under unchanged lymphocyte exposure; the same manipulation before initial attack will instead reduce killing. A factorial experiment restoring target recognition versus perturbing target caspases distinguishes this hypothesis from this hypothesis: increasing recognition alone will not remove these already recognized survivors, whereas delayed target-caspase perturbation will. Failure to demonstrate the timing-dependent sign reversal, despite verified target engagement, rejects the proposed mechanism.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.; Disordered protein LAT encodes relative levels of signaling pathways in T cell activation.; Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells..
6 papers retrieved around this hypothesis
- Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells.PMID 42268711 · full_text · 70,411 characters stored
- High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma.PMID 42608405 · full_text · 97,013 characters stored
- Disordered protein LAT encodes relative levels of signaling pathways in T cell activation.PMID 42060760 · full_text · 137,467 characters stored
- ViralMultiNet: A structure-aware multimodal framework for viral protein function prediction in wastewater surveillance.PMID 42234710 · full_text · 74,685 characters stored
- The digital keystone: how artificial intelligence is reshaping HLA research and clinical practice.PMID 42043567 · full_text · 100,557 characters stored
- AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.PMID 42410432 · full_text · 293,269 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.